Claire E. Repellin

Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors

Dalia Ercan, Chunxiao Xu, Masahiko Yanagita et al. · Cancer Discovery · 2012 · 291 citations · Full text

Medicine, Oncology, Pharmacology +17

Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway

Alexis B. Cortot, Claire E. Repellin, Takeshi Shimamura et al. · Cancer Research · 2012 · 183 citations · Full text

Medicine, Oncology, Pharmacology +16

Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors

Takayuki Kosaka, Junko Tanizaki, Raymond M. Paranal et al. · Cancer Research · 2017 · 129 citations · Full text

Medicine, Oncology, Pharmacology +15

Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia

Milena Gasco, Alex Sullivan, Claire E. Repellin et al. · Oncogene · 2002 · 103 citations

Medicine, Molecular Biology, Molecular Genetics +16

Concomitant inactivation of p53 and Chk2 in breast cancer

Alexandra Sullivan, Martin Yuille, Claire E. Repellin et al. · Oncogene · 2002 · 91 citations

Medicine, Molecular Genetics, Oncology +14